[Reduction of hyperfibrinemia in the nephrotic syndrome using defibrase].
D012103:Batroxobin / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications*; D010447:Peptide Hydrolases / Q000627:therapeutic use*
D005340:Fibrinogen; D010447:Peptide Hydrolases; D012103:Batroxobin
Réduction de l'hyperfibrinémie des syndromes néphrotiques par la défibrase